Artur Malzyner
Artur Malzyner publishes mostly in Oncology, Surgery and Pulmonary and Respiratory Medicine, on topics such as Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies and Advanced Breast Cancer Therapies.
- World rank
- #5,306,851 of 7,710,434 ranked researchers
- Rank in Brazil
- #107,139 of 253,246
- Works
- 20
- Citations
- 176
- Citations per work
- 8.8
What does Artur Malzyner research?
Artur Malzyner's work is mostly in Medicine (58%), Biochemistry, Genetics and Molecular Biology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1257.5%
- Medicine1257.5%
- Everything else631.3%
- Life Sciences211.2%
- 1Oncology28% of their works
- 2Surgery13% of their works
- 3Pulmonary and Respiratory Medicine11% of their works
- 4Molecular Biology6% of their works
- 5Dermatology6% of their works
- 6Cancer Research6% of their works
Research topics
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Advanced Breast Cancer Therapies
- Breast Cancer Treatment Studies
- Chemotherapy-induced cardiotoxicity and mitigation
- Chemotherapy-related skin toxicity
- Inflammatory mediators and NSAID effects
- Women's cancer prevention and management
Which keywords describe Artur Malzyner's research?
The keywords of their largest research topics: Metastatic Breast Cancer, Chemotherapy, Quality of Life, Molecular Subtypes, Breast Cancer, Chemotherapy-Induced Peripheral Neuropathy, Taxanes and CDK4/6 Inhibitors.
- Papanicolaou Test
- Extravasation
- Dermatological Toxicity
- Cervical Cancer
- Gene Expression
- Prevention
- KRAS Mutations
- CDK4/6 Inhibitors
- Chemotherapy-Induced Peripheral Neuropathy
- Molecular Subtypes
- Chemotherapy
- Metastatic Breast Cancer
- Quality of Life
- Breast Cancer
- Taxanes
- Cetuximab
- Palbociclib
- Breast Tumours
- Anthracyclines
- Cyclooxygenase-2 Inhibitors
- Doxorubicin
- Inflammation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Metastatic Breast Cancer102 topics
- Chemotherapy83 topics
- Quality of Life82 topics
- Molecular Subtypes72 topics
- Breast Cancer62 topics
- Chemotherapy-Induced Peripheral Neuropathy61 topic
- Taxanes61 topic
- CDK4/6 Inhibitors41 topic
- Cetuximab41 topic
- KRAS Mutations41 topic
- Palbociclib41 topic
- Prevention42 topics
- Breast Tumours31 topic
- Gene Expression31 topic
- Anthracyclines21 topic
- Cervical Cancer21 topic
- Cyclooxygenase-2 Inhibitors21 topic
- Dermatological Toxicity21 topic
- Doxorubicin21 topic
- Extravasation21 topic
- Inflammation21 topic
- Papanicolaou Test21 topic
Where does Artur Malzyner work?
Artur Malzyner's main affiliation in the publication record is Dr. Euryclides Hospital de Jesus Zerbini, Brazil.
How many publications and citations does Artur Malzyner have?
OpenAlex counts 20 works and 176 citations for Artur Malzyner, an h-index of 5, ranking #5,306,851 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Artur Malzyner. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.